Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Update: Growth And Opportunities In Peripheral Artery Disease

Executive Summary

Drug-coated balloon (DCBs) catheters have become the latest weapon in the fight against peripheral artery disease in the US, although they have been in use in Europe for some time. While the number of procedures employing DCBs is still dwarfed by conventional angioplasty procedures, they are expected to grow at a much faster rate, fueling a market projected to reach $1 billion by 2020; meanwhile other procedures such as mechanical atherectomy are also expected to show significant growth.


Related Content

SurModics Recruits Abbott To Commercialize SurVeil Drug-Coated Balloon
Starts & Stops: New Trial Starts Led By Peripheral Vascular Interventions
OUS Approvals Analysis: Medtronic, Abbott, Abionic Lead 2017 Upswing
Robert Byrne: Absorb, Synergy, And The Future Of Coronary Stents
Slow, Steady Growth For Interventional Cardiology
Drug-Coated Balloons Net Medicare Inpatient Bonus Payments
Let The U.S. Drug-Coated Balloon Battle Begin
Peripheral Artery Disease: Treatments And Diagnostics Poised For Growth
Drug-Coated Balloons Fuel Multibillion-Dollar Hopes


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts